RGV 105
Alternative Names: RGV-105Latest Information Update: 12 May 2022
At a glance
- Originator RNAGENE
- Class Influenza virus vaccines; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Influenza virus infections
Most Recent Events
- 19 Apr 2022 Early research in Influenza virus infections (Prevention) in South Korea (unspecified route) (RNAGENE pipeline, April 2022)